Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer

[1]  A. Lloyd,et al.  Milestones in cell division: Cell senescence and cancer , 2001, Nature Reviews Cancer.

[2]  E. Blackburn.  Switching and Signaling at the Telomere , 2001, Cell.

[3]  Steven A. Rosenberg,et al.  Progress in human tumour immunology and immunotherapy , 2001, Nature.

[4]  R. Scott,et al.  Phagocytosis and clearance of apoptotic cells is mediated by MER , 2001, Nature.

[5]  W. Gerald,et al.  Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.

[6]  D. Pinkel,et al.  Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. , 2000, The American journal of pathology.

[7]  R. DePinho,et al.  Cellular Senescence Minireview Mitotic Clock or Culture Shock? , 2000, Cell.

[8]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[9]  D. Pinkel,et al.  Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. , 1999, The Journal of investigative dermatology.

[10]  M. Mihm,et al.  Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. , 1999, Human pathology.

[11]  J. Shay,et al.  Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma. , 1999, Neoplasia.

[12]  D. Hicklin,et al.  Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression. , 1999, The American journal of pathology.

[13]  A. Amon.  The spindle checkpoint. , 1999, Current opinion in genetics & development.

[14]  U. Ringborg,et al.  N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. , 1998, The Journal of investigative dermatology.

[15]  K. Kinzler,et al.  The Genetic Basis of Human Cancer , 1997 .

[16]  D. Brash,et al.  Sunlight and the onset of skin cancer. , 1997, Trends in genetics : TIG.

[17]  W. Mooi,et al.  Quality assessment by expert opinion in melanoma pathology: experience of the Pathology Panel of the Dutch Melanoma Working Party , 1997, The Journal of pathology.

[18]  A. Marghoob,et al.  A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature. , 1997, Journal of the American Academy of Dermatology.

[19]  M. Raftery,et al.  Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients , 1997, The Lancet.

[20]  J. Becker,et al.  Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma. , 1996, The Journal of clinical investigation.

[21]  E. Farmer,et al.  Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. , 1996, Human pathology.

[22]  B. Gilchrest,et al.  Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating BCL-2 levels. , 1996, Experimental cell research.

[23]  T. Jacks,et al.  Sunburn and p53 in the onset of skin cancer , 1994, Nature.

[24]  K. Head.  Pathology of the skin , 1970, Veterinary Record.

[25]  P. H. Mckee,et al.  PATHOLOGY OF THE SKIN , 1940 .